🇨🇦
MCCQE1,2 | #Case_107 | #answer
〰〰〰〰〰〰〰〰〰〰〰〰〰〰
✅
C
🔎 Explanation
This patient is complaining of nights sweats few hours after taking NPH and insulin aspart mix and his morning fasting glucose levels are 12.2 mmol/L (220 mg/d). Morning hyperglycemia in diabetic patients may be caused by the
dawn phenomenon or the
Somogyi’s effect, or simply poor glycemic control.The dawn phenomenon is associated with physiological (or pathological)
decreased insulin secretion in the early
morning hours, accompanied by increase of
counterregulatory hormones, particularly the growth hormone. It can occur in patients with type 1 diabetes mellitus and type 2 diabetes mellitus. On the other hand, the
Somogyi’s effect seems to be most associated with type 1 diabetes and its incidence is increased in young people who take NPH insulin. Hyperglycemia is usually preceded by
hypoglycemia few hours earlier due to the effects of insulin treatment and this could be symptomatic or asymptomatic. This patient’s night time excessive sweating is most likely caused by hypoglycemia. It has been observed that in these patients the symptoms are not linked to the level of serum glucose itself as much as to the abrupt drop of it. A patient whose serum glucose dramatically falls from 5.6 mmol/l (100 mg/dl) to 3.3 mmol/l (60 mg/dl) in an hour is more likely to be symptomatic than a patient whose serum glucose level gradually decreases from 5.6 mmol/l (100 mg/dl) to 3.3 mmol (45 mg/dl) over 24 hours. For patients on NPH insulin treatment, hypoglycemic events can be connected with the evident peak of its concentration, taking place 4-5 hours after evening injections. The best recommendation to manage Somgyi's effect is to replace NPH insulin with a peakless long-acting analogue such as glargine or detemir
(choice C).
⚠ Nocturnal hormonal measurements
(choice A) have shown that patients with morning hyperglycemia have increased counterregulatory hormones, with growth hormone and glucagon being the most significant and consistent. This patient's condition is rather obvious and it's more appropriate to change from NPH insulin to long acting insulin than perform more diagnostic studies.
⚠ Reduce the evening dose of insulin by half
(choice B) is incorrect. In patients treated with NPH insulin who present with hypoglycemia and Somogyi’s effect, the best treatment is switching to peakless long-acting insulin such as glargine or detemir; however, if, for some reason, NPH insulin must be used, an alternative is to subtract 2 units from 10 units and use 8 units. Studies have shown that too rapid reduction in insulin dose can cause persistent severe hyperglycemia and ketonuria.
⚠ Double the dose of NPH and insulin aspart
(choice D) is incorrect. This reasoning is based on the wrong assumption, that the patient is not receiving enough insulin treatment but the symptoms of hypoglycemia he experiences in the night suggest the contrary.
⚠ No change in treatment, eat some sugar if sweating develops in the night
(choice E) is incorrect. This management has been associated with even higher and longer-lasting morning hyperglycemia.
🔖Key point:
Morning hyperglycemia following hypoglycemia in a type I diabetes patient treated with NPH insulin suggests Somogyi's effect. The best management is to replace the insulin therapy with long-acting insulin such as glargine or detemir